Steven Cohen's position in Cogent Biosciences is currently worth $26.6 Million. That's 0.08% of their equity portfolio (291st largest holding). The investor owns 3.98% of the outstanding Cogent Biosciences stock. The first Cogent Biosciences trade was made in Q4 2020. Since then Steven Cohen bought shares eight more times and sold shares on seven occasions. The investor's estimated purchase price is $49.6 Million, resulting in a loss of 46%.